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FGF-2-Responsive Neural Stem Cell
Proliferation Requires CCg, a Novel
Autocrine/Paracrine Cofactor
including steroid hormones, aging, environmental en-
richment, genetic background, stresses, and running
(Gould et al., 1992; Kuhn et al., 1996; Kempermann et
al., 1997a, 1997b; Gould et al., 1998; Van Praag et al.,
1999). However, the molecules and mechanisms con-
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The Salk Institute trolling neural stem or progenitor cell proliferation re-
10010 North Torrey Pines Road main only partially understood. Mitogens like epidermal
La Jolla, California 92037 growth factor (EGF) and FGF-2 influence the extent and
‡Department of Clinical Chemistry rate of proliferation of neural stem and progenitor cell
University Hospital populations in vitro and in vivo (Reynolds and Weiss,
S-22185 Lund 1992; Richards et al., 1992; Vescovi et al., 1993; Gage
Sweden et al., 1995b; Palmer et al., 1995, 1999; Kuhn et al., 1997;
Shihabuddin et al. 1997; Wagner et al., 1999; Roy et al.,
2000), and studies from single cell cultures show that
EGF and FGF-2 are mitogens for mouse-derived neu-Summary
rospheres (Reynolds and Weiss, 1996; Gritti et al., 1996)
and that other unknown factors, present in conditionedWe have purified and characterized a factor, from the
medium (CM), are required to support neural stem cellconditioned medium of neural stem cell cultures,
proliferation (Temple, 1989; Kilpatrick and Bartlett, 1993;which is required for fibroblast growth factor 2’s
Davis and Temple, 1994; Qian et al., 1997; Palmer et al.,(FGF-2) mitogenic activity on neural stem cells. This
1997; Johansson et al., 1999).autocrine/paracrine cofactor is a glycosylated form of
We previously established long-term cultures, in thecystatin C (CCg), whose N-glycosylation is required
presence of FGF-2, of adult rat hippocampus-derivedfor its activity. We further demonstrated that, both in
neural progenitor cells (AHPs) (Gage et al., 1995b) andvitro and in vivo, neural stem cells undergoing cell
also of adult rat neural progenitor cells derived fromdivision are immunopositive for cystatin C. Finally, we
other areas of the adult brain (Palmer et al., 1995, 1999;showed in vivo functional activity of CCg by demon-
strating that the combined delivery of FGF-2 and CCg Shihabuddin et al. 1997). We have previously cloned
to the adult dentate gyrus stimulated neurogenesis. AHPs and have shown that all three lineages are gener-
We propose that the process of neurogenesis is con- ated from single genetically marked cells and that the
trolled by the cooperation between trophic factors and cloned AHPs display stem cell properties, including the
autocrine/paracrine cofactors, of which CCg is a pro- capacity for self-renewal and retaining their multilineage
totype. potential (Palmer et al., 1997; Takahashi et al., 1999).
We have also grafted AHPs in the brain, where they
integrate and differentiate into terminally differentiatedIntroduction
neurons, appropriate for the area to where they were
grafted (Gage et al., 1995b; Suhonen et al., 1996; Taka-Neurogenesis, first thought to be limited to the prenatal
hashi et al., 1998). We observed that FGF-2 requires aperiod, occurs throughout adulthood in discrete regions
high cell density for culturing AHPs and also for culturingof the brain, such as the subventricular zone (SVZ) (Lois
neural progenitor cells from other areas of the brain,and Alvarez-Buylla, 1993; Luskin, 1993) and the sub-
whereas the expansion of clonal populations of AHPs,granular zone (SGZ) of the dentate gyrus (DG) of the
and also of neural progenitor cells from other areas ofhippocampus of several species, including human (Alt-
the brain, from single cells with FGF-2 was unsuccessful,man and Das, 1965; Caviness, 1973; Eriksson et al.,
unless FGF-2 was supplemented with AHP CM.1998). Stem cells are defined as undifferentiated cells
We postulated that FGF-2 requires cooperation withthat display high proliferative potential, generate a wide
an unknown autocrine/paracrine cofactor(s), present invariety of differentiated progeny including the principal
the CM, to support neural hippocampal stem cell prolif-phenotypes of the tissue, possess the capacity for self-
eration in vitro. We further postulated that the CM-renewal, and retain their multilineage potential over time
derived cofactor potentiates the activity of FGF-2 in vivo(Gage et al., 1995a). The process of neurogenesis in-
and therefore cooperates with FGF-2 to induce prolifera-cludes proliferation, migration, survival and differentia-
tion of endogenous neural stem cells in the adult hippo-tion into postmitotic neurons of the putative neural stem
campus. Our results have lead to the discovery of acells. During brain development, an excess of neural
novel autocrine/paracrine factor that cooperates withcells is produced; the cells migrate toward their target,
where a limited supply of trophic factors, produced by FGF-2 to stimulate the proliferation of neural stem cells
the target cells, regulates their survival (Oppenheim, in vitro and neurogenesis in vivo. Furthermore, this dis-
1991). Neurogenesis is regulated by a variety of stimuli, covery permits the formulation of the hypothesis that
trophic factors can achieve activity, and therefore speci-
ficity, through required interaction with local autocrine§ To whom correspondence should be addressed (e-mail: gage@
salk.edu). or paracrine cofactors.
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Figure 1. In Vitro Proliferation Assay and Pu-
rification of the Cofactor
AHPs, plated at different cell densities in N2,
N2 1 FGF-2, CM, and CM 1 FGF-2, were
counted at DIV 1 (A) and DIV 5 (B). FGF-2
alone supports proliferation of AHPs at densi-
ties . 200 cells per well; at lower densities,
CM is required. The purified 21 kDa protein
([D], arrow) exhibited most of the mitogenic
activity ([C], fraction 11) at DIV 5 and DIV 7.
In (C), between DIV 1 and 3 a large number
of cells died, probably from the toxic com-
pounds eluted from the membranes. Molecu-
lar weight markers (Mr) are indicated ([D], ar-
rowhead). Data in (A) and (B) are means 6
SEM of six independent experiments, and
data in (C) are the means of triplicate from
one of two typical independent experiments.
Results from 10 pg/ml to 100 ng/ml and tested alone or in combi-
nations, with or without FGF-2—failed to mimic the ac-
tivity of the CM (Table 1). Heparin, a factor known toIn Vitro Proliferation Assay
To demonstrate the requirement of an autocrine/para- potentiate FGF-2 (Baird, 1994; Caldwell and Svendsen,
1998), was also tested at concentrations ranging fromcrine cofactor to support the mitogenic activity of FGF-2,
AHPs were plated in cell culture medium (N2 medium) 2 ng/ml to 100 mg/ml and did not potentiate FGF-2’s
mitogenic activity at cell densities below 200 cells platedat densities at which the cells would die in the presence
of FGF-2 alone but would proliferate with FGF-2 supple- per well in the in vitro proliferation assay (Table 1). Statis-
tical analysis by one-way ANOVA showed that there wasmented by AHP CM (Figure 1A). FGF-2 alone (N2 1
FGF-2) supported the proliferation of AHPs when plated no difference between the four different conditions at
DIV 1 [F(3,30) 5 0.83, p . 0.5]. At DIV 5, one-way ANOVAat densities greater than 200 cells per well (0.32 cm2
surface area, Figure 1B). At lower densities (1–200 cells showed a significant effect due to treatments [F(3,30) 5
27.34, p , 0.0001]. Specific comparisons showed signif-per well), cells cultured in N2 medium alone (N2) or with
FGF-2 alone died by 5 days in vitro (DIV 5), whereas CM icant differences between all conditions (p , 0.0006),
except between N2 and N2 1 FGF-2 or CM and CM 1or CM containing FGF-2 (CM 1 FGF-2) supported their
proliferation (Figure 1B). Thus, the mitogenic activity FGF-2. Comparisons made above and below 200 cells
plated per well showed a significant difference for FGF-of FGF-2 is cell density dependent, with high-density
cultures producing sufficient amounts of a cofactor(s) 2 [t(9) 5 2.66, p , 0.026] and CM [t(4) 5 3.17, p , 0.034].
to support FGF-2’s mitogenic activity, whereas low-den-
sity cultures produced an insufficient amount of cofactor Purification and Characterization of the Cofactor
To purify the cofactor, large quantities of CM were gen-to cooperate with any levels of FGF-2 to support cell
proliferation. The observed mitogenic activity of the CM erated from the AHPs. The cofactor was purified and
analyzed by SDS-PAGE; a 21 kDa protein (Figure 1D,in the absence of FGF-2 is likely due to the continued
presence of an adequate concentration of FGF-2 added arrow) exhibited most of the activity in the in vitro prolif-
eration assay (Figure 1C, fraction 11). N-terminal se-for culturing. Different trophic factors/cytokines, includ-
ing EGF—tested at different concentrations ranging quencing of the protein yielded a sequence signal of
CCg: A Neural Stem Cell Factor
387
Table 1. Effect of Neurotrophic Factors/Cytokines on AHPs Plated at Low Density
Cell Number
Trophic Factor/Cytokine
Number of FGF-2 1 FGF-2 (20 ng/ml)
DIV 1 DIV 5 DIV 1 DIV 5
FGF-2 (20 ng/ml) 15.3 6 0 6.6 6 3 42.1 6 12 3.6 6 1
FGF-2 (100 ng/ml) 41.7 6 11 2.9 6 1
Heparin (2 mg/ml) 14.6 6 2 3.0 6 0 10.6 6 2 2.0 6 2
FGF-1 (40 ng/ml) 31.6 6 1 0.3 6 0 34.3 6 8 0.6 6 0
FGF-4 (40 ng/ml) 31.6 6 2 6.0 6 2 25.3 6 2 0.0 6 0
FGF-7 (20 ng/ml) 14.6 6 2 8.0 6 2 14.6 6 0 8.0 6 2
NGF (50 ng/ml) 35.5 6 9 8.8 6 5 33.3 6 12 5.9 6 3
BDNF (20 ng/ml) 36.4 6 14 5.4 6 5 38.9 6 12 5.6 6 8
NT-3 (40 ng/ml) 30.6 6 0 1.0 6 0 28.3 6 2 2.0 6 1
EGF (40 ng/ml) 39.3 6 3 0.6 6 0 36.6 6 1 2.0 6 1
CNTF (40 ng/ml) 25.3 6 2 0.6 6 0 25.3 6 0 0.3 6 0
PDGF (40 ng/ml) 23.3 6 2 0.0 6 0 17.1 6 1 0.0 6 0
GDNF (20 ng/ml) 16.6 6 2 0.0 6 0 19.6 6 2 0.0 6 0
IL-3 (20 ng/ml) 32.0 6 4 1.6 6 0 20.6 6 6 1.3 6 0
IL-4 (20 ng/ml) 50.6 6 3 2.3 6 0 46.3 6 3 9.0 6 5
IL-6 (20 ng/ml) 18.0 6 4 1.6 6 0 18.6 6 6 0.3 6 0
TNF-a (10 ng/ml) 37.9 6 9 7.3 6 2 37.9 6 8 9.0 6 4
PTN (20 ng/ml) 20.3 6 2 0.0 6 0 24.6 6 4 2.3 6 2
Activin (20 ng/ml) 26.3 6 0 0.0 6 0 37.6 6 5 0.0 6 0
TGF-a (40 ng/ml) 21.3 6 4 1.0 6 0 17.6 6 3 0.6 6 0
TGF-b (20 ng/ml) 26.0 6 3 0.0 6 0 36.3 6 3 0.0 6 0
IGF-I (20 ng/ml) 16.0 6 2 2.6 6 1 17.3 6 3 0.0 6 0
IGF-II (20 ng/ml) 17.0 6 1 2.0 6 1 21.0 6 4 2.6 6 0
MIP-1a (6 ng/ml) 11.6 6 2 0.3 6 0 12.0 6 0 0.3 6 0
MIP-1b (40 ng/ml) 13.6 6 2 1.0 6 0 19.3 6 0 0.3 6 0
Rantes (20 ng/ml) 20.6 6 5 0.0 6 0 18.0 6 2 0.0 6 0
SCF (20 ng/ml) 28.0 6 4 5.1 6 0 10.6 6 6 0.5 6 0
Trophic factors/cytokines were tested at different concentrations ranging from 10 pg/ml to 100 ng/ml. None of the factors tested mimicked
the activity of the CM. Heparin, a factor known to potentiate FGF-2 (Baird, 1994), was also tested at concentrations ranging from 2 ng/ml to
100 mg/ml and did not potentiate FGF-2’s mitogenic activity in the in vitro proliferation assay.
low intensity (GXSXXXXXLLGAXQXADA) that matched N-Glycosylation Is Essential for CCg’s Activity
Cystatin C, a cysteine proteinase inhibitor (Turk andthe N-terminal sequence of rat cystatin C (Esnard et al.,
Bode, 1991), is a molecule with pleiotropic functions,1990). The identity of the 21 kDa protein was further
with specific domains of the molecule involved in spe-confirmed by amino acid sequencing and mass spectral
cific functions (Machleidt et al., 1989; Leung-Tack et al.,analysis of the tryptic peptide fragments. All of the deter-
1990). Cystatin C is secreted by different cell types inmined sequences (Figure 2A; 84% of the 21 kDa protein
vitro (Warfel et al., 1987). It is expressed in the brainwas sequenced) matched rat cystatin C (Esnard et al.,
(Yasuhara et al., 1993), where it is associated with cere-1990). Two peptides, G1752 and G1751, were identified
bral pathologies such as cerebrovascular amyloidosisas full-length and N-terminally truncated rat cystatin C,
(Turk and Bode, 1991). Rat cystatin C is a 13–14 kDarespectively. Peptide G1754 contained a consensus site
basic protein (Turk and Bode, 1991) containing uniquefor N-glycosylation. The discrepancy between the ex-
consensus sites for N- (Asn-79-X-Thr) and O-glycosyla-perimental mass and the theoretical mass calculated
tion (Ser-3) (Esnard et al., 1990). The existence of afrom the backbones for the peptides G1750, G1751,
glycosylated form of cystatin C has been reported inG1752, and G1754 indicated that they were indeed gly-
rat seminal vesicles (Esnard et al., 1988). However, thecosylated (Figure 2A). Furthermore, the mass spectro-
type(s) of glycosylation, N-linked and/or O-linked, andscopic patterns of the peptides G1751 (Figure 2B) and
their functional relevance have not been investigated.
G1754 (Figure 2C) were characteristic of N-glycosylated
In the in vitro proliferation assay, CCg at concentra-
peptides, indicating that the 21 kDa protein is a glycosy- tions between 0.02 and 2 ng/ml induced cell proliferation
lated form of cystatin C (CCg). The deduced mass of in a dose-dependent manner and was potentiated by
the N-linked carbohydrate moiety is approximately 2.4 FGF-2 (Figure 3B). To investigate the importance of the
kDa, corresponding to 15 hexose residues. A carbohy- N-linked carbohydrate moiety, CCg was treated with
drate moiety of 0.3 kDa is present at the O-glycosylation PNGase F, an amidase that removes N-linked oligosac-
site (peptide G1750). The molecular weight of 21 kDa, charides from glycoproteins by cleaving the N-glyco-
as estimated by SDS-PAGE, was higher than the value sidic bond between Asn and the first hexoseamine. On
obtained by mass spectral analysis (16 kDa, G1752, Fig- SDS-PAGE, the N-deglycosylated CCg (CCg-DG) exhib-
ure 2A). This discrepancy may be due to the basic nature ited a shift in molecular weight to 19 kDa and appeared
of the protein and the presence of covalently bound sharper than the 21 kDa band, which migrated as a
diffuse band due to the presence of the carbohydratescarbohydrates (Hames, 1981).
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Figure 2. Sequencing and Mass Spectral Analysis of the 21 kDa Protein
The 21 kDa protein and the peptide G1751 were digested with trypsin and endoproteinase Asp-N, respectively. The peptides, separated by
HPLC, were submitted to chemical sequence and mass spectral analysis. All the sequences determined (A) matched rat cystatin C. The
peptide G1754 carries a N-linked carbohydrate moiety. Residues in parentheses were determined with less than 70% confidence. If two
residues are listed in parentheses, no unambiguous assignment could be made. X denotes that no assignment could be made with .50%
confidence. Peaks represent the different ionized forms of peptide G1751 (B) and the heterogeneity of the carbohydrate moiety of peptide
G1754 (C). m/z is the mass to charge ratio, Mn1 denotes the molecular mass of singly, doubly, and triply charged species, M is the average
molecular mass calculated from these charge states (B).
(Figure 3A, lane 2 versus lane 1, arrows) (Keinanen, induced cell proliferation in a dose-dependent manner
(Figure 3F). While the protease inhibitor-deficient mutant1988). CCg-DG exhibited no mitogenic activity (Figure
3B). The importance of glycosylation of CCg is under- (i2g1) retained the activity, the glycosylation-deficient
form (i1g2) did not. The present data show that, whereasscored by the fact that chicken cystatin (chCystatin),
which is structurally related to rat cystatin C but lacks the N-linked carbohydrate moiety is necessary for the
activity of CCg, the protease inhibitory domain is notthe N-glycosylation consensus sequence and thus is
not glycosylated (Turk and Bode, 1991), had no activity directly involved. One-way ANOVA analysis of data (Fig-
ure 3B) showed that there was a significant main effect(Figure 3C). In fact, it competitively inhibited the mito-
genic activity of CCg (Figure 3B) and of the CM (Figure due to treatments [F(2,6) 5 54.73, p , 0.001], with a
significant increase in cell number with increasing con-3C). In addition, neither the purified peptide of 22 amino
acid length containing the N-carbohydrate moiety (pep- centration [F(6,12) 5 21.8, p , 0.0001] as well as a
significant concentration and treatment interactiontide G1754) nor the N-carbohydrate moiety elicited any
activity in the in vitro proliferation assay. The recovery [F(12,36) 5 6.23, p , 0.0001]. Specific comparisons
showed significant differences (p , 0.01) between allof 100% of the CM activity with CCg, together with the
inhibition of the CM activity by the nonglycosylated form groups. For concentrations from 200 pg/ml and higher,
there is also a significant main effect on treatmentsof cystatin, indicate that the activity in the CM may be
accounted for by CCg. [F(3,8) 5 61.8, p , 0.0001] and no significant differences
between CCg-DG and CCg 1 chCystatin.To further investigate the importance of N-glycosyla-
tion versus the protease inhibitory domains for the activ-
ity of CCg, three recombinant forms of the mouse glyco- Cloning of Neural Stem Cells In Vitro
To investigate the ability of CCg to promote the prolifera-cystatin C were engineered (Figure 3D): (1) a wild-type
form (i1g1); (2) a mutant form (i2g1), in which the prote- tion and expansion of neural stem cells at clonal densi-
ties, single AHPs were plated in N2, N2 1 FGF-2, N2 1ase inhibitory site was deleted by truncating the 11 N-ter-
minal amino acids; and (3) a second mutant form where CCg, and N2 1 FGF-2 1 CCg (Table 2). While N2 alone
did not support cell growth, in N2 1 FGF-2 and N2 1the N-glycosylation site was mutated by substituting
Asn-79 for Asp (i1g2). Protease inhibitor-deficient forms CCg, 1% and 5% of single cells, respectively, grew
clones to a maximum cell number of 55 before they died.have been shown to lose their protease inhibitory activity
and exist in vitro and in vivo (Machleidt et al., 1989). On In contrast, in the presence of FGF-2 1 CCg, 31% of
single cells expanded to a confluent population andSDS-PAGE, the i1g1 form migrated at 16 kDa, the i2g1
form at 17 kDa and the i1g2 form, as reported for mouse were passaged (Figures 4A–4D). We have investigated
the presence of tubulin-b III, a neuronal marker, O4,cystatin C (Hakansson et al., 1996), at 12 kDa (Figure
3E). The wild-type form i1g1, at concentrations between an oligodendrocytic marker, and glial fibrillary acidic
protein (GFAP), an astrocytic marker, in the culture2 and 200 ng/ml in the presence of 20 ng/ml FGF-2,
CCg: A Neural Stem Cell Factor
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Figure 3. Structural Basis for the Activity of CCg
SDS-PAGE and silver staining of CCg untreated ([A], lane 1) or treated with PNGase F ([A], lane 2). CCg but not the N-deglycosylated form,
CCg-DG, induced proliferation of AHPs plated at low density; FGF-2 (20 ng/ml) potentiated the activity of CCg, whereas chCystatin (1 mg/
ml, nonglycosylated form of cystatin) inhibited it (B). ChCystatin did not induce the proliferation of AHPs in the absence or presence of
FGF-2, but inhibited cell proliferation induced by CM or CM 1 FGF-2 (C). Three recombinant forms of the mice glycocystatin—wild type (i1g1),
a form lacking the protease inhibitory site (i2g1), and a form with mutated N-glycosylation site (i1g2)—were engineered (D) and purified to
homogeneity ([E], the form i1g2 migrated at 12 kDa, arrow). In (D), NLT is the consensus site for N-glycosylation, DLT is the mutated site
where Asn has been subsituted for an Asp; a His tag was fused in 39 to the recombinant sequences. Only the forms i1g1 and i2g1, but not
i1g2, induced the proliferation in the presence of FGF-2 (F). The number of cells at DIV 5 were in (B) for N2, 0; N2 1 FGF-2, 5.10 6 0.3 (purple
line); CM, 354.64 6 40.3; CM 1 FGF-2, 360.00 6 33.3 (gray line); in (C) for N2, 0.33 6 0.3; N2 1 FGF-2, 0.33 6 0.3; CM, 280.82 6 40.5; CM 1
FGF-2, 306.44 6 45.5; and in (F) for N2, 0.33 6 0.3; N2 1 FGF-2, 0.33 6 0.3 (purple line); CM, 31.00 6 5.0; CM 1 FGF-2, 30.33 6 4.4 (gray
line). The number of cells plated at DIV 1 were in (B) for N2, 92.88 6 14.2; N2 1 FGF-2, 84.88 6 4.7; CM, 119.10 6 9.2; CM 1 FGF-2, 95.76 6
6.3; CCg, 83.96 6 4.0; CCg 1 FGF-2, 87.98 6 3.1; CCg-DG, 81.89 6 7.8; CCg 1 chCystatin, 85.16 6 6.9; in (C) for N2, 65.32 6 15.6; N2 1
FGF-2, 72.64 6 22.3; CM, 70.82 6 10.5; CM 1 FGF-2, 76.44 6 10.5; N2 1 chCystatin, 67.52 6 5.8; N2 1 FGF-2 1 chCystatin, 72.12 6 8.2;
CM 1 chCystatin, 69.65 6 4.2; CM 1 FGF-2 1 chCystatin, 67.48 6 8.3; and in (F) for N2, 24.80 6 0.2; N2 1 FGF-2, 26.40 6 2.6; CM, 24.00 6
1.8; CM 1 FGF-2, 26.00 6 4.4; i1g1, 22.25 6 1.6; i2g1, 20.39 6 1.4; i1g2, 23.06 6 2.6. Data in (B) and (F) are the means of triplicate from one
of three typical experiments, and data in (C) are means 6 SEM of three independent experiments.
generated with FGF-2 1 CCg. Less than 0.01% of the for O4, and 8% for GFAP. Time lapse experiments were
also performed on single plated AHPs in the presence ofcells exhibited differentiated phenotypes and were
astrocytes; no oligodendrocytes and no neurons were FGF-2 1 CCg (Figures 4E–4P). Each single cell produced
two daughter cells, both undergoing cell division. There-observed (data not shown), indicating that FGF-2 1 CCg
treatment does not differentiate AHPs toward any lin- fore, FGF-2 in the presence of CCg induces the cloned
cells to undergo symmetrical division, suggesting thateage. It has been reported that retinoic acid (RA) differ-
entiates neural stem and progenitor cells toward the the cloned cells are capable of self-renewing. The
cloned AHPs were further subcloned and tested forneuronal lineage, a low concentration of FGF-2 (2 ng/
ml) differentiates the cells toward the oligodendrocytic multipotentiality. All three lineages were generated from
single cells in the presence of both FGF-2 and CCg (datalineage, and fetal bovine serum (FBS) differentiates the
cells toward the astrocytic lineage (Palmer et al., 1997; not shown). Taken together, these results show that
(1) the cultured AHP population is heterogeneous—itTakahashi et al., 1999). To demonstrate the multipotenti-
ality of the cloned cells, we analyzed two passaged contains some stem cells, but also other neural progeni-
tor cells at different stages of maturation, as previouslyclones after differentiation in the presence of RA, a low
concentration of FGF-2 and FBS. Both clones generated observed (Palmer et al., 1997); (2) FGF-2 alone is not
sufficient to promote the proliferation of neural stemneurons, oligodendrocytes, and astrocytes (Figure 4D).
Of the cells, 5% were positive for tubulin-b III, 0.50% cells from a single AHP, although it elicits a weak mito-
Neuron
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Table 2. Number of Clones and Average Clone Size
Cell Type DIV 1 DIV 3 DIV 5 DIV 10 DIV 15 .DIV 15
AHPs
N2 98 (1) 27 (3.2 6 1.0) 3 (2.3 6 0.3) 0 (2) 0 (2) 0 (2)
N2 1 FGF-2 80 (1) 23 (2.8 6 0.3) 11 (6.0 6 2.7) 3 (23.0 6 19.5) 1 (55) 0 (2)
N2 1 CCg 21 (1) 17 (2.2 6 0.2) 16 (5.2 6 1.4) 5 (11.6 6 5.9) 1 (5) 0 (2)
N2 1 FGF-2 1 CCg 19 (1) 14 (5.5 6 1.7) 11 (15.0 6 5.0) 6 (67 6 18.6) 6 (247.1 6 52.5) 6 passaged
E17 HPC
N2 3084 (1) 0 (2) 0 (2) 0 (2) 0 (2) 0 (2)
N2 1 FGF-2 4665 (1) 103 (1) 9 (1) 1 (1) 0 (2) 0 (2)
CM 648 (1) 277 (1) 0 (2) 0 (2) 0 (2) 0 (2)
CM 1 FGF-2 690 (1) 342 (1) 38 (1) 14 (1.07 6 0.07) 14 (1.46 6 0.5) 1 expanded
N2 1 CCg 685 (1) 0 (2) 0 (2) 0 (2) 0 (2) 0 (2)
N2 1 FGF-2 1 CCg 909 (1) 72 (1) 48 (1) 16 (1.6 6 0.1) 9 (6.11 6 1.0) 8 expanded
N2 1 FGF-2 1 chCystatin 1644 (1) 7 (1) 2 (1) 0 (0) 0 (2) 0 (2)
Quantitation of clone numbers and sizes at DIV 1, DIV 3, DIV 5, DIV 10, and DIV 15. Single cells were cultured in N2, N2 1 FGF-2, CM, CM 1
FGF-2, N2 1 CCg, N2 1 FGF-2 1 CCg, and N2 1 FGF-2 1 chCystatin. Numbers in parentheses correspond to the average sizes of the clones.
FGF-2 and CCg are required to expand AHP and E15 primary hippocampal (E17 HPC) clones from a single cell. Cells were plated at a density
of 1 cell per well for AHPs and 20–25 cells per well for E17 HPC cells.
genic activity on neural progenitor cells, as they did not FGF-2, and the residual FGF-2 bound to the surface of
the cultured cells (Rogelj et al., 1988) could cooperateexpand farther than a few cell divisions; and (3) CCg acts
in cooperation with FGF-2 to promote the proliferation of with CCg to promote AHP proliferation temporarily.
Therefore, the cooperation of the two factors, FGF-2 andneural stem cells from a single AHP, as the cloned cells
retained their self-renewal and multipotential properties. CCg, is needed for FGF-2-induced mitogenic activity on
hippocampal rat neural stem cells in vitro and for theirCCg in association with FGF-2 is also required to
induce proliferation of embryonic (E17) rat primary hip- expansion from a single cell.
pocampal neural progenitor cells plated at low density
(Figures 4Q–4T and Table 2). In contrast to AHPs, no In Vitro and In Vivo Distribution of Cystatin C
AHPs and the DG of the adult rat hippocampus, a neuro-activity of CCg alone was observed on embryonic (E17)
rat primary hippocampal neural progenitor cells plated genic region (Altman and Das, 1965; Caviness, 1973;
Eriksson et al., 1998), were evaluated for the distributionat low density (Table 2). As opposed to embryonic (E17)
rat primary hippocampal neural progenitor cells, AHPs of cystatin C immunopositive cells (Figure 5). No Triton
X-100 was used during the staining of the AHPs to labelhave been cultured through several passages with
Figure 4. Cloning and Differentiation of Neu-
ral Stem Cells In Vitro
AHPs plated as single cells (A box) were cul-
tured in the presence of N2 1 FGF-2 1 CCg
(cells in [A]–[C] were from the same well; [A],
DIV 3; [B], DIV 7; [C], DIV 15), were differenti-
ated with RA, FGF-2, and FBS after passag-
ing, and were examined by immunocytofluor-
escence (D). The three main phenotypes of
the brain were detected: tubulin-b III–positive
neurons (green), GFAP-positive astrocytes
(purple), and O4-positive oligodendrocytes
(red, arrow). Nuclei (blue) were stained with
DAPI (D). Time lapse study on AHPs plated
as single cells ([E], 18 hr; [F], 22 hr 30 min;
[G], 23 hr; [H], 42 hr; [I], 43 hr; [J], 44 hr; [K],
50 hr 30 min; [L], 51 hr; [M], 58 hr; [N], 72 hr;
[O], 81 hr 30 min; [P], 84 hr 30 min after plat-
ing). AHPs are rounding-up before dividing
and the two daughter cells are dividing. Em-
bryonic (E17) rat primary hippocampal neural
progenitor cells plated at low density were
cultured in the presence of N2 1 FGF-2 1
CCg (cells in [Q]–[T] are from the same well;
[Q], DIV 6; [R], DIV 7; [S], DIV 12; [T], DIV 15).
CCg in cooperation with FGF-2 could also
induce proliferation of embryonic rat primary
hippocampal neural progenitor cells plated at
low density. Scale bars: 100 mm (A–C); 10 mm
(D–P); 20 mm (Q–T).
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Figure 5. Immunofluorescence Labeling of
Cystatin C in AHPs and in the Dentate Gyrus
of the Adult Rat Hippocampus
AHPs were stained for cystatin C (red) and
DAPI (blue) (A–G). Most of the AHPs immuno-
positive for cystatin C were in mitosis, as ob-
served by the DAPI staining of the chromo-
somes ([A and B], AHP in prophase; [C], AHP
in metaphase; [D], AHP in anaphase; [E], AHP
in telophase). Not all the AHPs in mitosis were
cystatin C–positive ([A], arrow; [F–G], AHPs
in telophase). Hippocampal sections of rats
injected with BrdU 2 hr before sacrifice were
stained for cystatin C (red). Cystatin C–pos-
itive cells were distributed throughout the
hippocampus, particularly along the SGZ of
the DG (H). Colabeling of the hippocampal
sections with cystatin C and BrdU (green)
shows that neural progenitor cells in the SGZ
undergoing cell division, as revealed by BrdU
labeling, were cystatin C–positive ([I], arrows).
Not all the neural progenitor cells undergoing
cell division were cystatin C–positive ([I], ar-
rowhead). By colabeling the hippocampal
sections with BrdU (green, [K]), cystatin C
(red, [L]), and GFAP (blue, [M]), we observed
BrdU and cystatin C colabeled cells that were
GFAP negative in the SGZ ([J], [J] is a merge
picture of [K], [L], and [M]). Cystatin C and
GFAP colabeled cells that were BrdU-nega-
tive cells were also observed ([J], arrow). The
two forms of cystatin C were revealed by
SDS-PAGE and silver staining from a cyto-
solic extract of adult rat hippocampus (N):
the band at 21 kDa, corresponding to CCg
(arrow), and the band at 19 kDa, correspond-
ing to the nonglycosylated form of cystatin
C (arrowhead). In situ hybridization study for
cystatin C mRNA shows strong hybridization
for cystatin C mRNA (arrows) in the SGZ of
the adult rat DG (O and P). The brain sections
were stained with nuclear fast red after per-
forming the in situ hybridization. Scale bars:
20 mm (A, H–I, and P); 5 mm (B–G and J–M);
100 mm (O).
extracellular cystatin C. Of the AHPs in culture, 1.40% served cystatin C and GFAP colabeled cells throughout
the brain (data not shown and Figure 5J), as previouslywere immunopositive for cystatin C (Figure 5A). DAPI
was used to identify AHPs in mitosis, based on the observed (Yasuhara et al., 1993). In the SGZ, 50% of
the cells undergoing cell division (BrdU-positive) weremorphology of their DNA (Figures 5B–5G). Approxi-
mately 2.55% of the AHPs were in mitosis (Figure 5A). positive for cystatin C (Figure 5I), and none of the cells
positive for BrdU and cystatin C were GFAP-positiveStrikingly, most of the AHPs immunopositive for cystatin
C were in mitosis, and the AHPs immunopositive for (Figures 5J–5M). We also observed cystatin C and BrdU
colabeled cells that were GFAP-negative cells through-cystatin C represented 54% of all the cells identified in
mitosis (Figure 5A). We conclude that this antibody for out the SVZ (data not shown), another neurogenic region
(Lois and Alvarez-Buylla, 1993; Luskin, 1993; Doetschcystatin C, in the absence of Triton X-100, labels mainly
a subpopulation of the AHPs that are undergoing cell et al., 1999). We conclude that in vivo as well as in vitro,
this antibody for cystatin C labels a subpopulation ofdivision. Immunohistology was performed on adult rat
brain fixed sections (Figures 5H–5M). Rats (Fischer-344, neural stem/progenitor cells undergoing cell division.
By treatment of the CM with PNGase F and Westernmales weighting 200–220 g) were injected with bromo-
deoxyuridine (BrdU, 150 mg/kg) 2 hr before sacrifice. blot analysis, we observed that the antibody against
cystatin C specifically recognizes the glycosylated cys-BrdU is a thymidine analog that incorporates into the
DNA of dividing cells and is used for birthdating cells tatin, CCg, and the nonglycosylated cystatin (data not
shown). Therefore, although the antibody against cys-and monitoring cell proliferation (Kuhn et al., 1996).
Since BrdU and GFAP are intracellular antigens, the tatin C did not specifically detect CCg, these results
confirm the involvement of cystatin C in adult neuro-staining was performed in the presence of Triton X-100.
Cystatin C–positive cells were distributed sparsely genesis.
To show that CCg was present in the adult rat hippo-throughout the brain, particularly in the SGZ of the hip-
pocampal DG (data not shown and Figure 5H). We ob- campus, we performed a papain chromatography from
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a cytosolic extract of adult rat hippocampus. The eluate positive cells that were FG negative was observed 11
days after grafting in the DG at the proximal areas ofwas analyzed by SDS-PAGE. The two forms of cystatin
C were revealed: the band at 21 kDa, corresponding to the grafted AHPs coexpressing FGF-2-S and i1g1 com-
pared to the proximal areas, where either AHPs coex-CCg, and, the band at 19 kDa, corresponding to the
nonglycosylated form of cystatin C (Figure 5N). To show pressing FGF-2-S and i1g2 or AHPs were grafted (Fig-
ures 6F–6H). In contrast, at distal areas of the grafts, thethe presence of cells expressing cystatin C in the SGZ,
we performed an in situ hybridization study of the DG numbers of BrdU-positive cells that were FG negative
remained at basal levels in all groups (Figures 6F, 6G,of the adult rat hippocampus for cystatin C mRNA. This
study revealed strong hybridization for cystatin C mRNA and 6I).
The generation of new neurons was assessed byin the SGZ (Figures 5O and 5P) and reflected the pattern
observed by immunostaining with the antibody against counting tubulin-b III and BrdU colabeled cells that were
FG negative (Figure 6E) in the proximal and distal areascystatin C (Figure 5H).
Cystatin C has been reported to be involved in cell of the grafts (Figures 6J and 6K). A 4-fold increase in
tubulin-b III and BrdU colabeled cells that were FG nega-migration and metastasis (Sloane et al., 1990). Recently,
Huh et al. (1999) observed in a knock-out model of cys- tive was observed in the proximal areas of the grafted
AHPs coexpressing FGF-2-S and i1g1, compared to alltatin C that the reduction of metastasis was associated
with a reduction in cell growth. This finding suggests other groups. Our data indicate that FGF-2 and CCg
cooperate to stimulate neurogenesis in the DG of thethat cystatin C is not only involved in metastasis but also
in cell growth, as we observed. We have investigated the adult rat hippocampus and that the N-glycosylation of
CCg is a requirement to stimulate neurogenesis in therate of proliferation in the DG of adult cystatin C–defi-
cient mice, as assessed by BrdU labeling. Mice (C57BL/ presence of FGF-2.
6J, 30- to 45-day-old female weighting 20–21 g) were
injected with BrdU (50 mg/kg) three times at 12 hr inter- Discussion
vals and were sacrificed 2 hr after the last injection.
A total of 1054.00 6 131.18 BrdU-positive cells were Neural stem and progenitor cells, isolated from diverse
counted in cystatin C–deficient mice versus 2622.00 6 regions of the adult brain, can be expanded in vitro in
295.94 BrdU-positive cells in wild-type littermate con- the presence of FGF-2 (Gage et al., 1995b; Palmer et
trols (n 5 6 per group), corresponding to a decrease al., 1995, 1999; Shihabuddin et al. 1997; Roy et al., 2000).
of approximately 60% in cell proliferation in the DG of Here we show that FGF-2 requires a high cell density
cystatin C–deficient mice versus wild-type littermate to support neural stem and progenitor cell proliferation.
controls. No difference in the volume of the DG was At low cell density, FGF-2 alone does not support neural
observed in cystatin C–deficient mice versus wild-type stem cell proliferation or survival, and it elicited a weak
littermate controls, 0.27 6 0.01 mm3 versus 0.26 6 0.01 mitogenic activity on neural progenitor cells, as they did
mm3, respectively. Although these results confirm the not expand farther than a few cell divisions. Supplemen-
involvement of cystatin C in adult neurogenesis, they tation with CM from neural stem and progenitor cell
do not resolve the specific role of the carbohydrate culture can overcome these limitations and allows neural
moiety of CCg in cell proliferation in vivo. A knock-in stem and progenitor cells to proliferate. Together these
mouse in which the asparagine of the N-glycosylation findings demonstrate the existence of an autocrine/par-
consensus site is substituted by an aspartic acid would acrine cofactor to support FGF-2’s mitogenic activity
be critical to investigate the importance of the N-glyco- on neural stem cells in vitro. Studies from single cell
sylation domain for the activity of CCg. cultures show that EGF and FGF-2 are mitogens for
mouse-derived neurospheres (Reynolds and Weiss,
1996; Gritti et al., 1996), and it has been previously re-Stimulation of Neurogenesis In Vivo
To investigate the ability of CCg to stimulate neurogen- ported that the cloning of neural stem cells requires
other factors present in CMs, none of which has beenesis, AHPs were genetically modified (Gage et al., 1995b)
to coexpress a secreted form of FGF-2 (FGF-2-S), con- identified (Temple, 1989; Kilpatrick and Bartlett, 1993;
Davis and Temple, 1994; Qian et al., 1997; Palmer et al.,structed by fusing the pre-pro sequence of the human
nerve growth factor (NGF) 59 to the rat FGF-2 sequence 1997; Johansson et al., 1999). We have purified a CM-
derived factor, CCg, that is required with FGF-2 to sup-(Ray et al., 1995) and either the wild-type form of CCg
(i1g1) or the glycosylation-deficient form (i1g2). AHPs port the proliferation in vitro of neural stem cells from
the adult rat hippocampus and for their expansion fromprelabeled with fluorogold (FG) were grafted in adult rat
hippocampus, the rats were injected with BrdU for 11 a single cell. We conclude that neural stem or progenitor
cells cultured from the adult rat hippocampus synthe-days following grafting, and the proliferation of endoge-
nous progenitor cells was determined immunohisto- size and secrete CCg, which acts as an autocrine/para-
crine factor and, in cooperation with FGF-2, to supportchemically by counting the cells positive for BrdU that
were negative for FG (Figure 6A). BrdU-negative cells the proliferation of neural stem cells in vitro.
Furthermore, we report that the combined deliverythat were FG positive (Figure 6B) and BrdU-positive cells
that were FG positive (Figure 6C) were not included as of a secreted form of FGF-2 and CCg by genetically
manipulated AHPs stimulates neurogenesis in the adultthey were derived from the grafts. Cell proliferation was
monitored at proximal and distal areas to the grafts, rat hippocampus. Although the intracerebral administra-
tion of FGF-2 has been shown to stimulate neurogenesiswithin the granular layer of the DG (Figures 6F and 6G),
a neurogenic region (Altman and Das, 1965; Caviness, in the adult rat SVZ, FGF-2 alone in the adult rat hippo-
campus has a limited effect on the proliferation of neural1973; Eriksson et al., 1998). A 4-fold increase in BrdU-
CCg: A Neural Stem Cell Factor
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Figure 6. Stimulation of Neurogenesis in the
Adult Rat DG by Grafted AHPs Coexpressing
FGF-2-S and Either the Wild-Type Form of
CCg or the Form of CCg with Mutated N-Gly-
cosylation Site
AHPs prelabeled with FG were grafted in
adult rat hippocampus. Newborn cells were
detected by BrdU labeling (red) and grafted
AHPs were detected by FG labeling (green).
The proliferation of newly generated endoge-
nous progenitor cells was determined immu-
nohistochemically by counting the BrdU-pos-
itive cells (red) that were FG negative (A).
AHPs prelabeled with FG prior to grafting
were FG positive ([B], green). BrdU and FG
colabeled newly generated AHPs (C) were not
counted as they were derived from the grafts.
Neurons were stained for tubulin-b III (blue, [D]).
The generation of new neurons was deter-
mined by counting tubulin-b III and BrdU co-
labeled cells that were FG negative (E). (F)
and (G) are camera lucida drawings of the
distribution of BrdU-positive cells that were
FG negative (red triangles), outside the graft
area (blue line), in the DG of the hippocampus
(purple line) grafted with AHPs coexpressing
FGF-2-S and either the wild-type form of CCg
(i1g1, [F]) or the form of CCg with mutated
N-glycosylation site (i1g2, [G]). The quan-
tification of newborn cells proximal to the
grafts (H and J) was performed within the
granular layer of the DG, in a 280 mm area
from the edge of the graft (black segment),
and the quantification of newborn cells distal
to the grafts (I and K) was performed in a 280
mm area beginning at least 800 mm from the
tip of the graft. An increase in tubulin-b III
and BrdU colabeled cells that were FG nega-
tive was only observed in the proximal area
of the DG of the rats that received grafted
AHPs coexpressing FGF-2-S and i1g1. Con-
trol AHPs are presented. Scale bar: 5 mm
(A–E); 100 mm (F–G). Data are means 6 SEM
for four animals in each treatment group (*p ,
0.005 by two-way ANOVA).
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stem/progenitor cells (Kuhn et al., 1997; Wagner et al., observation that the N-glycosylation of CCg is neces-
1999). The differential effect of FGF-2 on stem/progeni- sary to support neural stem cell proliferation suggests
tor cells from the SVZ and the DG may be attributed to that the N-linked carbohydrate moiety, but not the prote-
different populations of stem/progenitor cells; alterna- ase inhibitory domain, is directly involved in the mecha-
tively, both cell populations are responsive to FGF-2 but nism of action of CCg. CCg could bind to FGF-2, and
may also require additional factor(s) (Kuhn et al., 1997; the resulting complex would result in a higher affinity
Wagner et al., 1999). Cystatin C has been identified in for FGF receptor. Alternatively, CCg and FGF-2 could
cerebrospinal fluid (Lofberg and Grubb, 1979), and we act synergistically in a receptor-mediated fashion to pro-
also observed cystatin C and BrdU colabeled cells that mote the proliferation of neural stem cells. This latter
were GFAP-negative cells throughout the SVZ (data not contention is supported by the finding that N-linked,
shown). Therefore, the administered FGF-2 could inter- but not O-linked, carbohydrate moieties interact with
act locally with CCg to support neurogenesis in the SVZ. specific receptors to mediate their functions, whereas
Since it has been reported that, depending on the mode deglycosylated proteins interact with receptors but are
of administration, FGF-2 could be rapidly cleared from unable to activate intracellular events, acting thereby as
the brain (Gonzalez et al., 1994), insufficient levels of competitive inhibitors of protein action (Sairam, 1989),
FGF-2 could prevent the stimulation of neurogenesis in as we observed for CCg. The nonglycosylated form of
the presence of CCg in the adult rat hippocampus. We cystatin C was found in larger amounts than the glycosy-
demonstrate that genetically engineered AHPs, which lated form in AHP CM and in the adult rat hippocampus
provide a means to locally deliver a transgene for a (Figure 5N), indicating that the activity of CCg is con-
sustained period of time (Gage et al., 1995b) by simulta- trolled by the synthesis and secretion of varying levels
neously producing FGF-2 and CCg, stimulate neurogen- of glycosylated versus nonglycosylated forms of cys-
esis in the DG 4-fold. We conclude that in vivo neurogen- tatin C. CCg is an autocrine/paracrine factor and pro-
esis is stimulated by the cooperation between FGF-2 motes the proliferation of neural stem cells in vitro and
and CCg. The involvement of CCg in adult neurogenesis in vivo. Therefore, the finding that the labeling of cystatin
is further confirmed by the observation of a decrease C is present on the extracellular plasma membrane of
of 60% in cell proliferation in the DG of adult cystatin the AHPs undergoing cell division could reflect that the
C–deficient mice, versus wild-type littermate controls. neural stem cells undergoing cell division bind CCg at
The decrease in cell proliferation is not associated with a their plasma membrane. Our data show that the prote-
decrease in the volume of the DG in cystatin C–deficient ase inhibitory domain of CCg is not directly involved in
mice versus wild-type littermate controls. Several hy- neural stem cell proliferation; however, it could second-
potheses can explain the lack of detectable change in arily support cell proliferation and migration by regulat-
the volume of the DG in cystatin C–deficient mice: (1) ing the environmental proteolytic activity (Galko and
there are approximately less than 1% of the cells that Tessier-Lavigne, 2000).
are dividing over weeks period in the adult DG, (2) the In summary, our results demonstrate that FGF-2 re-
rate of survival of the residual newborn cells can be quires a cofactor, CCg, for its mitogenic activity on neu-
extended by some other compensatory mechanisms, ral stem cells in vitro and to stimulate neurogenesis in
and (3) the cell density of the DG can also be altered. vivo. CCg is a 21 kDa glycosylated form of cystatin C,
Additional experiments will be needed to tease out if whose posttranslational N-glycosylation is necessary to
there are functional consequences in the behavior or induce neural stem cell proliferation. Trophic factors
the physiology of these mice, as well as developmental such as FGF-2 (Baird, 1994) have a broad range of bio-
consequences, that can be attributed to this decrease logical activities. Our findings show that their temporal
in cell proliferation in the DG. and spatial activity and, therefore, specificity may be
Therefore, the proliferation of neural stem cells in vitro achieved by cooperation with autocrine/paracrine co-
and in vivo neurogenesis are stimulated by the coopera-
factors, of which CCg is a prototype.
tion between FGF-2 and CCg. The postmitotic develop-
ment of most neuronal populations in vertebrate animals
Experimental Proceduresis characterized by a period of cell death during which
40%–60% of the neurons are eliminated (Oppenheim, Tissue Culture, Immunofluorescence Studies,
1991). The degree of cell death has been shown to be and In Situ Hybridization
controlled by the target tissues that the neurons inner- AHP cultures and immunofluorescence studies were performed as
described (Gage et al., 1995b). The CM was prepared by incubatingvate, via the restricted availability of neurotrophic fac-
60% confluent cells (passage 17–30) for 48 hr in DMEM/F12, supple-tors produced by target cells. We propose that the gen-
mented with 2.5 mM L-glutamine and N2 supplement (N2 medium)eration of new neurons in the nervous system could be
containing FGF-2 (20 ng/ml; recombinant human FGF-2; gift from
controlled by the cooperation between trophic factors A. Baird). The medium was replaced and conditioned for 2 more
and autocrine/paracrine factor(s). days. The CM was kept at 2808C until use. All the in vitro assays
Several hypotheses can be envisioned to explain how were performed in 96-well plates; cell proliferation was monitored
CCg and FGF-2 cooperate to stimulate neural stem cell by counting cells at DIV 1 and DIV 5 under a phase contrast micro-
scope (3 10). In such a proliferation assay, a net increase, or de-proliferation. CCg could cooperate with FGF-2 in an
crease, in cell number is the result of both cell proliferation and cellautocrine/paracrine manner to promote the mitogenic
survival. DAPI (49,6-diamidino-2-phenylindole, Sigma) staining wasactivity of FGF-2 on neural stem cells. Alternatively, CCg
performed on AHPs plated at low density, and cells in mitosis were
could promote the survival, or prevent the death, of the observed, confirming that cell division occurred (data not shown).
cells that can respond to the mitogenic activity of Cells were examined 4 hr after plating and wells containing clusters
FGF-2. Carbohydrate moieties have a broad range of of .1 cell were omitted from the experiments. For differentiation
experiments, cells were cultured in N2 medium containing all-transactivities and mechanisms of action (Varki, 1993). The
CCg: A Neural Stem Cell Factor
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RA (1 mM, Sigma), FGF-2 (2 ng/ml), and FBS (0.50%, Hyclone) for for i2g1: primers A, B, and C, 59 GTCCTGGGCGTGGCCTGGGCG
GCCCCGGAGGAGGCAGATGCC and D, 59 CGCCCAGGCCACGCC10 days. Time-lapse imaging was performed on a chamber mounted
on an inverted microscope (Nikon TE300) with a SPOT camera. CAGGAC; for i1g2: primers A, B, and E, 59 CGAACTACATGTAC
CAAGTCCCAGACAGATTTGACTGACTGT and F, 59 GGACTTGGTAImmunofluorescence was performed with the following primary anti-
bodies: tubulin-b III (1/1,000, Sigma), GFAP (1/500, Adv. Immuno.), CATGTAGTTCG. Each variant was further mutated to add an in-
frame histidine (His) tag at the C terminus. As a result of the cloningO4 (gift from O. Boegler), BrdU (1/100, Accurate), cystatin C (1/1,000,
Biogenesis), and FG (1/2,000, Chemicon). All secondary antibodies procedure, two differences in the nucleotide sequence of mouse
cystatin C were observed: the G in position 71 was found to be awere from Jackson. The detection of BrdU required pretreatment
of the sections in HCl 2N for 30 min at 408C. Streptavidin-biotin C, and the T in position 276 was found to be a G, when compared
to the published sequence (Solem et al., 1990). These nucleotideamplification was used when detecting FG. Triton X-100 (0.3%) was
used during the cytological and histological procedures to detect changes resulted in amino acid substitution of Gly (25) to Ala and
Phe (64) to Leu. These changes are homologous with sequencesintracellular antigens, such as tubulin-b III, GFAP, BrdU, cystatin C,
and FG. It was not used to reveal antigens present at the outer side from other species (Turk and Bode, 1991). At least seven clones of
each recombinant form were sequenced. The three recombinantof the plasma membrane, such as O4 and cystatin C. The use of
Triton X-100 did not alter the quality of the immunostaining. The in forms were subcloned into the retroviral vector NIT for use in tran-
sient retroviral production (Pear et al., 1993). NIT (GenBank acces-situ hybridization procedure was performed as described (Lein et
al., 1999). The probes used for in situ hybridization were prepared sion number AF311318) is a Moloney murine leukemia virus-based
retroviral vector with an expression cassette encoding a neomycinby digesting 5 mg of plasmid SPSK encoding mouse cystatin C (see
below). The antisens probe was prepared by digesting the plasmid resistance gene, an internal ribosomal entry site, and the tetracycline
transactivator. The transgene is expressed from a minimal CMVwith SfiI and was amplified with T7 polymerase, whereas the control
sens probe was prepared by digesting the plasmid with ClaI and promoter containing 6-tandem tetracycline operators. AHPs were
resuspended in N2 medium (1 ml) containing retrovirus and poly-was amplified with T3 polymerase.
brene (2 mg/ml, Sigma) for 30 min at 378C. The cells were cultured
and selected with G418 (400–1000 mg/ml). Recombinant proteinsProtein Purification
i1g1 and i2g1 were purified by submitting the CMs to Ni-NTA (Qia-CM (10 liters) were applied to lentil-lectin Sepharose 4B (25 ml,
gen) and lentil-lectin affinity chromatographies. Recombinant i1g2Sigma) equilibrated with 25 mM HEPES (pH 7.0), 1 mM MnCl2, and
was purified by submitting CM to Ni-NTA and papain affinity chro-1 mM CaCl2, and the column was washed with 25 mM HEPES (pH
matographies. The eluents were dialyzed against tissue culture me-6.5) and 50 mM NaCl. No mitogenic activity was detected in the
dium or 25 mM ammonium bicarbonate before lyophylisation. Start-flow-through. The column was eluted with 250 mM a-methyl-manno-
ing from the same amount of CM, similar amounts of the differentside. The eluent—with the mitogenic activity—was collected, con-
forms of recombinant cystatins were measured (data not shown).centrated (Biomax-5, Millipore), and applied to a strongly acidic
FGF-2-S (Ray et al., 1995) was subcloned into the retroviral vectorcation exchanger column (1 ml, Hi-TrapSP, Pharmacia). The nonad-
LPCX for use in transient retroviral production. LPCX is derivedsorbing effluent containing the mitogenic activity and was collected,
from retroviral vector LNCX (Genbank accession number M28247)concentrated, and resolved on a 15% SDS-PAGE under nonreduc-
through substitution of the neomycin with a puromycin resistanceing conditions, and the proteins were transferred to an Immobilon
gene. The transgene is expressed from a CMV promoter. AHPsPVDF membrane (Millipore) (Hames, 1981). For activity determina-
expressing cystatin variants were infected with LPCX-FGF-2-S, cul-tion, proteins were recovered as follows: after lentil-lectin and cation
tured, and coselected with G418 and puromycin (0.8–1 mg/ml).exchange chromatographies, 2 ml samples were collected, dialyzed
Transgene expression was characterized in both cystatin variants(3000 MWCO) against tissue culture medium, and filtered (0.22 mm).
and FGF-2-S coinfected AHPs by RNA blot analysis (data notAfter blotting, the membrane was cut into 20 equal fractions, and
shown).proteins were eluted (Montalero, 1987). Since the cofactor of FGF-2
was identified as cystatin C and cystatin C binds to papain with high
affinity (Turk and Bode, 1991), the 21 kDa protein was subsequently Surgical Procedures
purified by a modified protocol consisting of lentil-lectin affinity AHPs (75,000 cells in 1.5 ml) labeled for 4 hr prior to grafting with
chromatography followed by papain chromatography (Barret, 1981). FG (0.01%, Fluorochrome) (Erickson and Goins, 1995) were stereo-
CCg protein was purified to near homogeneity as shown by SDS- taxically injected into the hippocampus (anteroposterior axis, 23.5;
PAGE (Figure 3A, lane 1, compare with Figure 1D) and confirmed mediolateral axis, 63.0; dorsoventral axis, 23.9 from skull, with nose
by HPLC analysis (data not shown). bar at 5 mm up) of anesthetized male Fischer-344 rats (200–220 g).
Rats were administered a daily, intraperitoneal injection of BrdU (50
Protein Sequencing and Mass Spectroscopy mg/kg, Sigma) for 11 days following grafting. Then animals were
The protein band at 21 kDa was excised, and 250 pmol was sub- sacrificed and perfused (4% paraformaldehyde), and 40 mm thick
jected to in situ digestion with trypsin. The digested peptides were brain sections were cut on a freezing microtome. To assess the
separated by reverse phase HPLC. The resolved peaks were submit- relevance of the use of FG to segregate the grafted AHPs versus
ted to sequencing and mass spectral analysis. Peptide G1751 di- the endogenous cells, the following control experiments were per-
gested with endoproteinase Asp-N was separated by HPLC and formed. AHPs prelabeled with FG were cultured up to 11 days in
analyzed by sequencing and mass spectral analysis. Sequencing the presence of FGF-2 and were also cocultured up to 11 days in the
was performed on Perkin-Elmer/Applied Biosystems protein se- presence of FGF-2 with green fluorescent protein (GFP) transfected
quencer (models 470A and 494) (Fischer et al., 1991). All sequences AHPs. FG was still detectable in over 98% of the AHPs, and none
obtained were subjected to a BLAST computer homology search of the GFP-positive cells were labeled with FG, by immunocyto-
(Altschul et al., 1990). Major fractions were analyzed by matrix as- chemistry (data not shown), suggesting that even after several cy-
sisted laser desorption mass spectroscopy on a Bruker Reflex time- cles of division prelabeled AHPs remained FG immunodetectable
of-flight instrument. and that there was no transfer of FG to neighboring cells in vitro.
Thus, in the course of the in vivo experiment, AHPs prelabeled with
FG are likely to remain FG positive. AHPs prelabeled with FG werePlasmid Construction
Three recombinant forms of CCg were engineered by PCR amplifica- submitted to a few cycles of freezing and thawing; the resulting
dead AHPs were grafted in the hippocampus where we detectedtion from a plasmid encoding mouse cystatin C (ATCC 63,113): a
wild-type (i1g1), a mutant lacking the protease inhibitory site (i2g1), no FG-positive cells and no increase in cell proliferation in the DG.
Thus, there was no transfer of FG to neighboring cells and theand a mutant with a mutated N-glycosylation site (i1g2). To create
the mutant forms, sequential PCR amplifications using primers with surgery did not have a nonspecific effect on cell proliferation in the
DG (data not shown). The quantification of BrdU and tubulin-b IIIcompatible extensions to introduce base changes were used. Sets
of primers were paired appropriately to result in each construct—for cells proximal to the grafts was performed within the granular layer
of the DG, 280 mm area from the edge of the graft in four sectionsi1g1: primer A, 59 GAGAGAGAATTCATGGCCAGCCCGCTGCGC
TCC and B, 59 AGAGAGATCGATGGCATTTTTGCAGCTGAAATTT; using confocal scanning laser microscopy (Zeiss Axiovert and Bio-
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rad MRC1024). Similarly characterized cells distal to the grafts were planted to the adult brain. Proc. Natl. Acad. Sci. USA 92, 11879–
11883.counted in a 280 mm area beginning at least 800 mm from the tip
of the graft (Figures 6F and 6G). The edge of the graft was delimited Galko, M.J., and Tessier-Lavigne, M. (2000). Function of an axonal
under UV light, since FG is autofluorescent under UV light. The trace chemoattractant modulated by metalloprotease activity. Science.
of the edge of the graft corresponds to the limit where the UV light 289, 1365–1367.
began to lack continuity (Figures 6F and 6G, blue lines).
Gonzalez, A.M., Carman, L.S., Ong, M., Ray, J., Gage, F.H., Shults,
C.W., and Baird, A. (1994). Storage, metabolism, and processing of
Analytical Procedure and Data Analysis 125I-fibroblast growth factor-2 after intracerebral injection. Brain Res.
Protein concentrations were determined with Coomassie protein 665, 285–292.
assay reagent (Pierce). Group changes were assessed using one-
Gould, E., Cameron, H.A., Daniels, D.C., Woolley, C.S., and McEwen,and two-way ANOVA. When statistical differences were obtained at
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